A novel saponin liposomes based on the couplet medicines of Platycodon grandiflorum–Glycyrrhiza uralensis for targeting lung cancer

References

• Albuquerque HMT, Santos CMM, Silva AMS. (2018). Cholesterol-based compounds: recent advances in synthesis and applications. Molecules. 4:116.
   Google Scholar
• Amin MU, Ali S, Ali MY, et al. (2021). Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy. Eur J Pharm Biopharm. 165:31–40.
   PubMed Web of Science ®Google Scholar
• Bonanno L, Favaretto A, Rugge M, et al. (2011). Role of genotyping in non-small cell lung cancer treatment. Drugs. 71:2231–46.
   Google Scholar
• Cai Y, Xu Y, Chan HF, et al. (2016). Glycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapy. Mol Pharm. 13:699–709.
   PubMed Web of Science ®Google Scholar
• Capolla SJP. (2021). Nanoparticles-based oligonucleotides delivery in cancer: role of zebrafish as animal model. Pharmaceutics. 13:1106.
   PubMed Web of Science ®Google Scholar
• Chang TC, Huang SF, Yang TC, et al. (2007). Effect of ginsenosides on glucose uptake in human Caco-2 cells is mediated through altered Na+/glucose cotransporter 1 expression. J Agric Food Chem. 55:1993–8.
   PubMed Web of Science ®Google Scholar
• Chen Y, Sun Y, Zhao Q, et al. (2021). Shenmai injection enhances cisplatin-induced apoptosis through regulation of Mfn2-dependent mitochondrial dynamics in lung adenocarcinoma A549/DDP cells. Cancer Drug Resist. 4(4):1047–60.
   PubMedGoogle Scholar
• Hong C, Wang D, Liang J, et al. (2019). Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer. Theranostics. 9:4437–49.
   PubMed Web of Science ®Google Scholar
• Hu X, Subramanyam M, Lerner M, et al. (2009). Pharmacokinetic and pharmacodynamic profile of PEGylated interferon beta-1a in healthy volunteers: results from two clinical studies. Br J Clin Pharmacol. 79:514–22.
   Google Scholar
• Jiang Y, Liu LS, Shen LP, et al. (2016). Traditional Chinese medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: a randomized controlled trial. Complement Ther Med. 24:55–62.
   PubMed Web of Science ®Google Scholar
• Jung D-H, Nahar J, Mathiyalagan R, et al. (2022). Focused review on molecular signalling mechanisms of ginsenosides on anti-lung cancer and anti-inflammatory activities. Anticancer Agents Med Chem. 22:1875–5992.
   Google Scholar
• Legha SS, Muggia FM, Carter SKJC. (2015). Adjuvant chemotherapy in lung cancer. Rev Prospects. 39:1415–24.
   Google Scholar
• Li N, Mai Y, Liu Q, et al. (2020). Docetaxel-loaded d-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer ­chemotherapy and reverse multidrug resistance. Drug Deliv Transl Res. 11:131–41.
   Web of Science ®Google Scholar
• Li R, Zhang L, Li Z, et al. (2019). Characterization and absorption kinetics of a novel multifunctional nanoliposome stabilized by sea cucumber saponins instead of cholesterol. J Agric Food Chem. 68: 642–651.
   PubMed Web of Science ®Google Scholar
• Li Y-L, Lu S-M,Jian M. (2005). Effect of Chinese herb Platycodon grandiflorum on Roxithromycin concentration of lung tissue. J Tradit Chin Vet Med. 2005: 3–6.
   Google Scholar
• Lu L, Ding Y, Zhang Y, et al. (2018). Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII. Int J Nanomed. 13:1927–44.
   PubMed Web of Science ®Google Scholar
• Lu L, Dong J, Gong W, et al. (2022). Advances in basic research of traditional Chinese medicine herbal formulae in the treatment of non-small cell lung cancer. Tradit Med Modern Med. 1–11.
   Google Scholar
• Luo Y-H, Wang C, Xu W-T, et al. (2021). 18β-Glycyrrhetinic acid has anti-Cancer effects via inducing apoptosis and G2/M cell cycle arrest, and inhibiting migration of A549 lung cancer cells. Onco Targets Ther. 14:5131–44.
   PubMed Web of Science ®Google Scholar
• Meng LF, Huang JF, Luo PH, et al. (2022). The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis. Invest New Drugs. 40:810–17.
   PubMed Web of Science ®Google Scholar
• Moein Moghimi S, Hamad I, Bünger R, et al. (2006). Activation of the human complement system by cholesterol-rich and PEGylated liposomes-modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels. J Liposome Res. 16:167–74.
   PubMed Web of Science ®Google Scholar
• Monpara J, Kanthou C, Tozer GM, et al. (2018). Rational design of cholesterol derivative for improved stability of paclitaxel cationic liposomes. Pharm Res. 35:90.
   PubMed Web of Science ®Google Scholar
• Narendra, Mehata AK, Viswanadh MK, et al. (2020). Formulation and in vitro evaluation of upconversion nanoparticle-loaded liposomes for brain cancer. Ther Deliv. 11:557–71.
   PubMed Web of Science ®Google Scholar
• Passaro A, Brahmer J, Antonia S, et al. (2022). Managing resistance to immune checkpoint inhibitors in lung cancer: treatment and novel strategies. J Clin Oncol. 40: 598–610.
   PubMed Web of Science ®Google Scholar
• Ratan ZA, Haidere MF, Hong YH, et al. (2021). Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res. 45:199–210.
   PubMed Web of Science ®Google Scholar
• Saadat M, Mostafaei F, Mahdinloo S, et al. (2021). Drug delivery of pH-sensitive nanoparticles into the liver cancer cells. J Drug Deliv Sci Technol. 63:102557.
   Web of Science ®Google Scholar
• Shen F, Wu W, Zhang M, et al. (2019). Micro-PET imaging demonstrates 3-O-β-d-glucopyranosyl platycodigenin as an effective metabolite affects permeability of cell membrane and improves dosimetry of [18F]-phillygenin in lung tissue. Front Pharmacol. 10:1020.
   PubMed Web of Science ®Google Scholar
• Su Y, Wang L, Liang K, et al. (2018). The accelerated blood clearance phenomenon of PEGylated nanoemulsion upon cross administration with nanoemulsions modified with polyglycerin. Asian J Pharm Sci. 13:44–53.
   PubMed Web of Science ®Google Scholar
• Szebeni J, Baranyi L, Savay S, et al. (2000). Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated. Am J Physiol Heart Circ Physiol. 279:H1319.
   Google Scholar
• Yang B, Geng SY, Wang JY. (2013). Physical stability of cholesterol derivatives combined with liposomes and their in vitro behavior. Annu Int Conf IEEE Eng Med Biol Soc. 2013:4114–17.
   PubMedGoogle Scholar
• Yang EJ, Ju SM, Ku HY, et al. (2012). Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction. Biochem Biophys Res Commun. 421(4):658–64.
   PubMed Web of Science ®Google Scholar
• Zhao R, Chen M, Jiang Z, et al. (2015). Platycodin-D induced autophagy in non-small cell lung cancer cells via PI3K/Akt/mTOR and MAPK signaling pathways. J Cancer. 6:623–31.
   PubMed Web of Science ®Google Scholar
• Zhao RL, Zhang X, Chen MJ, et al. (2015). Research progress in anti-tumor mechanisms of platycodin-D. J Infrom Tradit Chin Med. 2015:126–129.
   Google Scholar
• Zhou L, Lu R, Liu Q, et al. (2020). Two branched fructose modification improves tumor targeting delivery of liposomes to breast cancer in intro and in vivo. J Drug Deliv Sci Technol. 61:102312.
   Web of Science ®Google Scholar
• Zhu J, Chen M, Chen N, et al. (2015). Glycyrrhetinic acid induces G1-phase cell cycle arrest in human non-small cell lung cancer cells through endoplasmic reticulum stress pathway. Int J Oncol. 46:981–8.
   PubMed Web of Science ®Google Scholar